Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nuclear receptor subfamily 1 group I member 2 | ||
Ligand | BDBM50317583 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_839534 (CHEMBL2090341) | ||
EC50 | >30000±n/a nM | ||
Citation | Tynebor, RM; Chen, MH; Natarajan, SR; O'Neill, EA; Thompson, JE; Fitzgerald, CE; O'Keefe, SJ; Doherty, JB Synthesis and biological activity of pyridopyridazin-6-one p38a MAP kinase inhibitors. Part 2. Bioorg Med Chem Lett22:5979-83 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Nuclear receptor subfamily 1 group I member 2 | |||
Name: | Nuclear receptor subfamily 1 group I member 2 | ||
Synonyms: | NR1I2 | NR1I2_HUMAN | Orphan nuclear receptor PAR1 | Orphan nuclear receptor PXR | PXR | Pregnane X receptor | SXR | Steroid and xenobiotic receptor | nuclear receptor subfamily 1 group I member 2 isoform 1 | ||
Type: | Nuclear receptor | ||
Mol. Mass.: | 49774.77 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O75469 | ||
Residue: | 434 | ||
Sequence: |
| ||
BDBM50317583 | |||
n/a | |||
Name | BDBM50317583 | ||
Synonyms: | 1-(2,6-difluoro-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl)-6-(2,4-difluorophenyl)-2H-quinolizin-2-one | CHEMBL1098546 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H13F4N3O2 | ||
Mol. Mass. | 451.3725 | ||
SMILES | Cc1nnc(o1)-c1cc(F)c(c(F)c1)-c1c2cccc(-c3ccc(F)cc3F)n2ccc1=O |(-7.52,-29.92,;-6.62,-31.17,;-5.08,-31.17,;-4.6,-32.63,;-5.84,-33.54,;-7.09,-32.63,;-5.85,-35.08,;-4.51,-35.86,;-4.51,-37.39,;-3.18,-38.17,;-5.85,-38.16,;-7.18,-37.4,;-8.51,-38.17,;-7.19,-35.86,;-5.85,-39.7,;-4.52,-40.48,;-3.2,-39.71,;-1.87,-40.47,;-1.87,-42.02,;-3.2,-42.78,;-3.2,-44.32,;-4.53,-45.09,;-4.54,-46.63,;-3.2,-47.4,;-3.2,-48.94,;-1.86,-46.62,;-1.87,-45.09,;-.54,-44.31,;-4.52,-42.02,;-5.85,-42.78,;-7.18,-42.02,;-7.18,-40.48,;-8.52,-39.71,)| | ||
Structure |